PhoenixBio Co., Ltd. (6190) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Forval RealStraight Inc.

ECOMIC CO., LTD.

Delivery Consulting, Inc.

JTEC Corp.

PhoenixBio Co., Ltd.

Palma Co. Ltd.

Japan Reliance Service Corp.

Kitac Corp.

Cacco, Inc.

BCC Co., Ltd.

ALiNK Internet, Inc.

Why is PhoenixBio Co., Ltd. ?

Poor Management Efficiency with a low ROE of 6.82%

The company has been able to generate a Return on Equity (avg) of 6.82% signifying low profitability per unit of shareholders funds

Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 6.82%

The company has declared positive results for the last 3 consecutive quarters

ROCE(HY) Highest at 8.58%
DEBTORS TURNOVER RATIO(HY) Highest at 10.22 times
NET PROFIT(Q) At JPY 31.76 MM has Grown at 80.16%

With ROE of 4.65%, it has a risky valuation with a 1.30 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of -14.06%, its profits have risen by 151.3% ; the PEG ratio of the company is 0.2

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -14.06% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to PhoenixBio Co., Ltd. should be less than 10%
Overall Portfolio exposure to Miscellaneous should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is PhoenixBio Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

PhoenixBio Co., Ltd.

-100.0%

-0.49

69.43%

Japan Nikkei 225

85.83%

3.09

27.80%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

10.31%

EBIT Growth (5y)

17.68%

EBIT to Interest (avg)

-52.54

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.53

Sales to Capital Employed (avg)

0.79

Tax Ratio

3.72%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

11.86%

ROE (avg)

6.82%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.30

EV to EBIT

15.67

EV to EBITDA

11.06

EV to Capital Employed

1.56

EV to Sales

0.78

PEG Ratio

0.18

Dividend Yield

ROCE (Latest)

9.95%

ROE (Latest)

4.65%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

14What is working for the Company

ROCE(HY)

Highest at 8.58%

DEBTORS TURNOVER RATIO(HY)

Highest at 10.22 times

NET PROFIT(Q)

At JPY 31.76 MM has Grown at 80.16%

-4What is not working for the Company

NET SALES(Q)

At JPY 364.82 MM has Fallen at -8.73%

RAW MATERIAL COST(Y)

Grown by 8.94% (YoY

CASH AND EQV(HY)

Lowest at JPY 2,202.51 MM

Here's what is working for PhoenixBio Co., Ltd.

Net Profit

At JPY 31.76 MM has Grown at 80.16%

over average net sales of the previous four periods of JPY 17.63 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (JPY MM)

Debtors Turnover Ratio

Highest at 10.22 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Depreciation

Highest at JPY 9.24 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (JPY MM)

Here's what is not working for PhoenixBio Co., Ltd.

Net Sales

At JPY 364.82 MM has Fallen at -8.73%

over average net sales of the previous four periods of JPY 399.69 MM

MOJO Watch

Near term sales trend is very negative

Net Sales (JPY MM)

Cash and Eqv

Lowest at JPY 2,202.51 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Raw Material Cost

Grown by 8.94% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales